Rhythm Pharmaceuticals, Inc. (RYTM)
99.02
+1.01
(+1.03%)
USD |
NASDAQ |
Sep 17, 16:00
99.75
+0.73
(+0.74%)
Pre-Market: 08:09
Rhythm Pharmaceuticals Total Return Level : 99.02 for Sept. 17, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 17, 2026 | 99.02 |
| September 16, 2026 | 98.01 |
| September 15, 2026 | 96.77 |
| September 14, 2026 | 102.44 |
| September 11, 2026 | 104.71 |
| September 10, 2026 | 102.20 |
| September 09, 2026 | 101.06 |
| September 08, 2026 | 101.80 |
| September 04, 2026 | 102.74 |
| September 03, 2026 | 104.89 |
| September 02, 2026 | 105.42 |
| September 01, 2026 | 104.74 |
| August 31, 2026 | 106.13 |
| August 28, 2026 | 107.17 |
| August 27, 2026 | 112.53 |
| August 26, 2026 | 111.87 |
| August 25, 2026 | 113.35 |
| August 24, 2026 | 111.44 |
| August 21, 2026 | 110.00 |
| August 20, 2026 | 108.92 |
| August 19, 2026 | 115.73 |
| August 18, 2026 | 115.25 |
| August 17, 2026 | 115.44 |
| August 14, 2026 | 115.48 |
| August 13, 2026 | 116.02 |
| Date | Value |
|---|---|
| August 12, 2026 | 117.60 |
| August 11, 2026 | 112.84 |
| August 10, 2026 | 115.48 |
| August 07, 2026 | 115.63 |
| August 06, 2026 | 112.10 |
| August 05, 2026 | 110.71 |
| August 04, 2026 | 105.78 |
| August 03, 2026 | 102.78 |
| July 31, 2026 | 99.25 |
| July 30, 2026 | 105.74 |
| July 29, 2026 | 106.53 |
| July 28, 2026 | 108.04 |
| July 27, 2026 | 106.13 |
| July 24, 2026 | 102.10 |
| July 23, 2026 | 102.66 |
| July 22, 2026 | 103.97 |
| July 21, 2026 | 106.60 |
| July 20, 2026 | 104.60 |
| July 17, 2026 | 106.60 |
| July 16, 2026 | 106.09 |
| July 15, 2026 | 109.69 |
| July 14, 2026 | 109.96 |
| July 13, 2026 | 107.49 |
| July 10, 2026 | 108.40 |
| July 09, 2026 | 115.48 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.45 |
| Alnylam Pharmaceuticals, Inc. | 245.51 |
| BioMarin Pharmaceutical, Inc. | 65.08 |
| Cytokinetics, Inc. | 69.92 |
| Exelixis, Inc. | 58.49 |